TY - JOUR
T1 - Experts' preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
AU - Beaudart, C.
AU - Bauer, J.M.
AU - Landi, F.
AU - Bruyere, O.
AU - Reginster, J.Y.
AU - Hiligsmann, M.
AU - ESCEO Working Group on Sarcopenia
AU - European Union of Geriatric Medicine Society (EUGMS)
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Background and aims To assess experts' preference for sarcopenia outcomes. Methods A discrete-choice experiment was conducted among 37 experts (medical doctors and researchers) from different countries around the world. In the survey, they were repetitively asked to choose which one of two hypothetical patients suffering from sarcopenia deserves the most a treatment. The two hypothetical patients differed in five pre-selected sarcopenia outcomes: quality of life, mobility, domestic activities, fatigue and falls. A mixed logit panel model was used to estimate the relative importance of each attribute. Results All sarcopenia outcomes were shown to be significant, and thus, important for experts. Overall, the most important sarcopenia outcome was falls (27%) followed by domestic activities and mobility (24%), quality of life (15%) and fatigue (10%). Discussion and conclusion Compared to patient's preferences, experts considered falls as a more important outcome of sarcopenia, while the outcomes fatigue and difficulties in domestic activities were considered as less important.
AB - Background and aims To assess experts' preference for sarcopenia outcomes. Methods A discrete-choice experiment was conducted among 37 experts (medical doctors and researchers) from different countries around the world. In the survey, they were repetitively asked to choose which one of two hypothetical patients suffering from sarcopenia deserves the most a treatment. The two hypothetical patients differed in five pre-selected sarcopenia outcomes: quality of life, mobility, domestic activities, fatigue and falls. A mixed logit panel model was used to estimate the relative importance of each attribute. Results All sarcopenia outcomes were shown to be significant, and thus, important for experts. Overall, the most important sarcopenia outcome was falls (27%) followed by domestic activities and mobility (24%), quality of life (15%) and fatigue (10%). Discussion and conclusion Compared to patient's preferences, experts considered falls as a more important outcome of sarcopenia, while the outcomes fatigue and difficulties in domestic activities were considered as less important.
KW - Discrete-choice experiment
KW - Sarcopenia
KW - Outcomes
U2 - 10.1007/s40520-021-01794-2
DO - 10.1007/s40520-021-01794-2
M3 - Article
C2 - 33666899
SN - 1594-0667
VL - 33
SP - 1079
EP - 1083
JO - Aging Clinical and Experimental Research
JF - Aging Clinical and Experimental Research
IS - 4
ER -